uniQure N.V. (QURE) announced on Wednesday that it has set the public offering price for approximately 4.4 million shares at $17 per share, successfully raising close to $75 million. Furthermore, the healthcare company is extending a 30-day option to underwriters, allowing them to acquire up to an additional 661,764 ordinary shares at the same price point. The offering is anticipated to conclude on or around January 10. Ahead of the market opening, uniQure's stock is experiencing a decline of 3.12%, trading at $17.02 on the Nasdaq.